About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

EUS-PPG vs HVPG in Portal Hypertension

NCT05689268·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospital General Universitario de Alicante

Age

18–100

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age above 18 years
Undergoing evaluation for chronic liver disease or portal hypertension
Signed informed consent

You may not be if

Uncorrectable coagulopathy (INR above 1.5)
Uncorrectable thrombocytopenia (Platelets under 50,000)
Anticoagulation or antiplatelet therapy that cannot be discontinued
Biliary obstruction
Grade II ascites or more
Intrahepatic portal vein thrombosis
Pregnancy

The record

StatusCompleted

PhaseNo phase

Taking part33

StartedFeb 2023

UpdatedSep 21, 2023

Conditions

Cirrhosis Portal Hypertension

Where1

Unidad de Endoscopia. Hospital General Universitario de Alicante
Alicante, Spain

Clareo Health | EUS-PPG vs HVPG in Portal Hypertension